Ambooj Tiwari, MD
Neurosurgery · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Offices
- 2
Offices
2 locations · Neuranimus P C · Physician Affiliate Group of New York PC
Hospitals listed: El Camino Health · South Brooklyn Health. That is not proof they admit you there this week.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tiwari’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
State licence records
1 licence
- New Jersey 25MA09637400Medical Doctor · since 2015 · expires 2027-06-30ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- South Brooklyn HealthBrooklyn, NYAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of New York City Health and Hospitals Corporation, which runs 12 hospitalsPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.317, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for South Brooklyn Health
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 3 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.91 (0 to 1.92) · 881 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.71 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 157.8 (101.02 to 214.58) · 34 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 179 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 157 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 450 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 698 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 236 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,493 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.05 to 0.45) · 6,081 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.44) · 6,217 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.57 (3.24 to 7.9) · 531 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 47 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.77 (0 to 18.62) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.1 (0.81 to 9.39) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.7 (0.11 to 1.28) · 5,664 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.821 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.665 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.6 · 164 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.5 · 586 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 49.7 · 108 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 38.9 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 115.2 · 661 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 21.4 · 720 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 282 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.1 to 16.8) · 126 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 42 cases | No different | Jan 2024 – Dec 2024 |
What patients said (451 patients answered, 11% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$19,784
Medicare paid this office $19,784 for 63 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $5,419 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,981 | $103 |
| Measurement of brain wave activity (eeg), awake and drowsy | 13 | $706 | $50 |
Who their Medicare patients are
63 Original Medicare patients in 2024. Average age 77 · Women 52% · Also on Medicaid 70% · Health risk score 2.24. Sicker patients than 9 in 10 peers; the typical neurosurgery clinician is at 1.46.
Conditions among them: High blood pressure 75% · Stroke 75% · Diabetes 70% · Coronary heart disease 52% · Dementia 44% · Heart failure 43% · Chronic kidney disease 41% · Atrial fibrillation 40% · Depression 30% · COPD 27%.
The office billed $73,088, Medicare allowed $24,949 and paid $19,784; for 143 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 63 | 143 | 77 | 2.24 | $73,088 | $19,784 |
| 2023 | 49 | 124 | 80 | 1.57 | $124,329 | $22,141 |
| 2022 | 31 | 101 | 75 | 2.15 | $54,432 | $15,951 |
| 2021 | 28 | 65 | 72 | 1.96 | $47,253 | $15,945 |
| 2020 | 38 | 104 | 76 | 1.56 | $79,676 | $28,072 |
| 2019 | 21 | 41 | 78 | 3.19 | $71,830 | $11,318 |
| 2018 | 57 | 179 | 76 | 1.56 | $191,400 | $33,855 |
| 2017 | 120 | 356 | 76 | 2.03 | $306,102 | $60,075 |
| 2016 | 117 | 274 | 78 | 1.72 | $333,057 | $39,097 |
| 2015 | 88 | 334 | 77 | 2.37 | $249,499 | $45,366 |
| 2014 | 53 | 206 | 74 | 1.99 | $219,172 | $20,884 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,750 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,083 | $106 |
2022: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $3,154 | $96 |
2020: 1 service
| Return visit (30+ min) | 14 | $2,484 | $104 |
2018: 3 services
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 12 | $4,488 | $345 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 13 | $3,688 | $263 |
| Return visit (30+ min) | 21 | $2,541 | $85 |
2017: 13 services
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 14 | $11,851 | $741 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,941 | $175 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 14 | $5,599 | $400 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 22 | $5,324 | $242 |
| Return visit (30+ min) | 25 | $4,095 | $93 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 11 | $3,347 | $304 |
| Critical care, first 30-74 minutes | 16 | $3,338 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,763 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $2,681 | $84 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 16 | $1,938 | $121 |
| New patient visit (45+ min) | 12 | $1,736 | $145 |
| Review by radiologist of pelvis artery image | 14 | $732 | $49 |
| 3d radiographic procedure with computerized image postprocessing | 11 | $595 | $35 |
2016: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $5,568 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,154 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,087 | $61 |
| Critical care, first 30-74 minutes | 14 | $2,859 | $191 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 11 | $1,729 | $144 |
| Return visit (30+ min) | 11 | $1,254 | $96 |
2015: 8 services
| Critical care, first 30-74 minutes | 26 | $5,958 | $205 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $5,581 | $95 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 13 | $4,148 | $296 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 12 | $3,368 | $259 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $3,140 | $65 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 11 | $2,888 | $263 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,037 | $185 |
| Review by radiologist of pelvis artery image | 14 | $842 | $56 |
2014: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $4,142 | $64 |
| Critical care, first 30-74 minutes | 17 | $3,372 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,660 | $92 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $766 | $35 |
Medicaid work
$1,087 in 2023
Medicaid paid $1,087 for 34 billed services this clinician did in 2023, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSP IP/OBS HIGH 75 | 18 | $721 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 16 | $366 |
| 2023 | 34 | 2 | 18 | $1,087 |
Drugs they prescribed that Part D paid
$938
Pharmacies billed $938 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 48) in 2024. Too few prescriptions to compare fairly with other clinicians.
45 generic and fewer than 11 brand-name prescriptions · $938 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Duloxetine | 12 | $50 | $4 |
Year by year
| 2024 | 48 | 20 | 0% (0) | None | $938 |
| 2018 | 40 | 12 | 0% (0) | None | $6,372 |
| 2017 | 72 | 22 | 0% (0) | 31% | $8,600 |
| 2016 | 129 | 27 | None | None | $9,335 |
| 2015 | 71 | 18 | None | 25% | $4,817 |
| 2014 | 18 | None | None | None | $814 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2017: 1 drug
| Lisinopril | 11 | $19 | $2 |
2016: 3 drugs
| Eliquis | 11 | $3,765 | $342 |
| Clopidogrel | 20 | $316 | $16 |
| Atorvastatin | 13 | $289 | $22 |
2015: 1 drug
| Atorvastatin | 15 | $171 | $11 |
Money from drug and device companies
$503 in 2025
| 2025 | 8 | 11 | None | $503 |
| 2024 | 5 | 8 | None | $211 |
| 2023 | 9 | 12 | None | $536 |
| 2022 | 3 | 5 | None | $214 |
| 2021 | 1 | 1 | None | $34 |
| 2019 | 6 | 16 | None | $674 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Eisai | Leqembi | $175 | 3 payments
|
| Amgen | None | $125 | 1 payment
|
| Pfizer | Eliquis | $44 | 2 payments
|
| Octapharma USA | Fibryga | $34 | 1 payment
|
| AngioDynamics | Smart Port Ct | $32 | 1 payment
|
| Abbvie | Qulipta | $32 | 1 payment
|
See all 11 published payments
| Octapharma USA | Meals · 2025-12-16 | Fibryga | $34 |
| Pfizer | Meals · 2025-11-19 | Eliquis | $25 |
| Amgen | Meals · 2025-11-13 | None | $125 |
| Eisai | Meals · 2025-10-14 | Leqembi | $125 |
| Pfizer | Meals · 2025-10-06 | Eliquis | $19 |
| AngioDynamics | Meals · 2025-09-19 | Smart Port Ct | $32 |
| Eisai | Meals · 2025-07-30 | Leqembi | $24 |
| Catalyst Pharmaceuticals | Meals · 2025-05-21 | Firdapse | $32 |
| Eisai | Meals · 2025-05-19 | Leqembi | $27 |
| Abbvie | Meals · 2025-04-10 | Qulipta | $32 |
| Imperative Care | Meals · 2025-02-21 | Zoom 88-T Large Distal Platform | $30 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $211
| Octapharma USA | Balfaxar | $75 | 2 payments
|
| SK Life Science | None | $64 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $28 | 1 payment
|
| Pfizer | Eliquis | $27 | 1 payment
|
| Eisai | Leqembi | $18 | 1 payment
|
2023: $536
| Imperative Care | Zoom Rdl Radial Access System, 103cm | $277 | 2 payments
|
| Argenx US | Vyvgart | $47 | 2 payments
|
| Penumbra | Red 72 | $47 | 1 payment
|
| SK Life Science | None | $45 | 2 payments
|
| Octapharma USA | Panzyga | $36 | 1 payment
|
| Pfizer | Eliquis | $25 | 1 payment
|
| Amneal Pharmaceuticals | Rytary | $21 | 1 payment
|
| Eisai | Leqembi | $20 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $17 | 1 payment
|
2022: $214
| Imperative Care | Zoom Reperfusion Catheter | $161 | 3 payments
|
| Medtronic | Pipeline | $35 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $18 | 1 payment
|
2021: $34
| Medtronic | Pipeline | $34 | 1 payment
|
2019: $674
| Stryker | Surpass | $249 | 5 payments
|
| Penumbra | Penumbra System | $198 | 4 payments
|
| Medtronic USA | Solitaire | $163 | 3 payments
|
| Teleflex | Guidewires | $27 | 2 payments
|
| DePuy Synthes Sales | Pulserider | $20 | 1 payment
|
| Asahi Intecc USA | Asahi Neurovascular Guide Wire | $16 | 1 payment
|
Professional record
- NPI
- 1609198779
- Licence
- NJ 25MA09637400, NY 276012-1New Jersey 25MA09637400: Active
- Group
- Neuranimus P C · Physician Affiliate Group of New York PC
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2084V0102X (2084V0102X); Federal specialty code 2085R0204X (2085R0204X)
- Mailing address
- 1511 3rd Ave Ste 1000, Seattle, WA, 98101
- NPI first listed
- 2010-02-17
- NPI last updated
- 2025-08-08
- NPI record certified
- 2025-08-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2200 Northern Blvd, Greenvale, NY, 11548